27-Jun-2026 10:39:32

AUROBINDO PHARMA : US FDA INSPECTION CONCLUDES WITH 2 OBSERVATIONS

• US FDA conducted an inspection at Auroactive Pharma Private Limited (a wholly owned subsidiary) • The inspection manufactured Active Pharmaceutical Ingredients (API) & Pharmaceutical Formulation Intermediates • The inspection was held from June 22, 2026, to June 26, 2026, and concluded with 2 observations • Aurobindo will respond to observations within the stipulated time • There is no impact on the Company's financials or operations Impact: Neutral (Routine inspection concluded with 2 observations, no immediate impact on financials or operations)

Aurobindo Pharma Limited

← Back to feed